The Molecular Recognition and Screening Shared Resource (MRSSR) provides VICC investigators with reagents, equipment, and expertise for the production, detection, and characterization of biomolecules. A major role for the MRSSR is to generate monoclonal and phage-displayed single-chain (ScFv) antibodies and to assist investigators in their use in a range of applications. Shared Resource staff also assist in the expression of protein antigens via insect cell expression, scale-up of monoclonal antibody production by growth of hybridomas, and scale-up of ScFvs by expression in E. coli. The insect cell culture facility is also used for high capacity protein expression for biophysical studies and drug screening. Beginning in early 2004, MRSSR staff will assist investigators in the performance of high throughput screens of a large chemical library for activities in vitro or in cell-based assays. Dr. Ray Mernaugh oversees the daily operations of the MRSSR. He has extensive experience in monoclonal and phage-displayed antibody generation as well as protein expression. He meets with users, trains MRSSR personnel, and oversees and coordinates the MSSR's budget, equipment, and use of facilities and services. He is assisted by a highly-trained and experienced staff who are able to help VICC investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA068485-11
Application #
7289851
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2006-09-01
Budget End
2007-08-31
Support Year
11
Fiscal Year
2006
Total Cost
$128,186
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Hebron, Katie E; Li, Elizabeth Y; Arnold Egloff, Shanna A et al. (2018) Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis. Sci Rep 8:3208
Bangaru, Sandhya; Zhang, Heng; Gilchuk, Iuliia M et al. (2018) A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nat Commun 9:2669
Gilchuk, Pavlo; Kuzmina, Natalia; Ilinykh, Philipp A et al. (2018) Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein. Immunity 49:363-374.e10
Du, Zhenfang; Lovly, Christine M (2018) Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer 17:58
Zhang, Qin; Jeppesen, Dennis K; Higginbotham, James N et al. (2018) Mutant KRAS Exosomes Alter the Metabolic State of Recipient Colonic Epithelial Cells. Cell Mol Gastroenterol Hepatol 5:627-629.e6
Means, Anna L; Freeman, Tanner J; Zhu, Jing et al. (2018) Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer. Cell Mol Gastroenterol Hepatol 6:257-276
Kook, Seunghyi; Qi, Aidong; Wang, Ping et al. (2018) Gene-edited MLE-15 Cells as a Model for the Hermansky-Pudlak Syndromes. Am J Respir Cell Mol Biol 58:566-574
Choksi, Yash A; Reddy, Vishruth K; Singh, Kshipra et al. (2018) BVES is required for maintenance of colonic epithelial integrity in experimental colitis by modifying intestinal permeability. Mucosal Immunol 11:1363-1374
Elion, David L; Cook, Rebecca S (2018) Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment. Oncotarget 9:29007-29017
Yang, Yaohua; Cai, Qiuyin; Shu, Xiao-Ou et al. (2018) Prospective study of oral microbiome and colorectal cancer risk in low-income and African American populations. Int J Cancer :

Showing the most recent 10 out of 2462 publications